Cargando…
Commentary on: SMARCB1 as a novel diagnostic and prognostic biomarker for osteosarcoma
In the last couple of decades, biomarkers have been on the rise for diagnostic and predictive value. There has been a rush to identify new markers using new technologies and drug repurposing approaches. SMARCB1 acronym arises from the SWI/SNF (SWItch/Sucrose Non-Fermentable)-related Matrix-associate...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202507/ https://www.ncbi.nlm.nih.gov/pubmed/35583077 http://dx.doi.org/10.1042/BSR20220040 |